Ignoring EFCA is bad for business Polley elevating food-store pharmacy Chances for biogenerics pathway bill dim in 2007 Tamper-proof Rx pad deadline prompts appeal NACDS claims victory on pivotal FDA bill provisions NACDS responds to "misleading" New York Times article Medela receives accreditation from ACHC Community pharmacy members collaborate to take Medicaid issues to Washington Wolfgram testifies to Senate on behalf of NACDS FDARA attempt to limit citizens petitions not likely to have much effect, expert claims First Previous 298 299 300 301 302 Next Last
